Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis

The initial area under the gadolinium curve (IAUGC) is often used in addition to or as an alternative to parameters derived from pharmacokinetic modelling of T1-weighted dynamic contrast-enhanced (DCE) MRI data in the assessment of response to treatment of cancer. However, the physiological meaning of the IAUGC has not been rigorously defined with respect to model-based parameters. Here, simulations of DCE-MRI data were used to investigate the relationship between IAUGC and the parameters Ktrans (transfer constant), ve (fractional extravascular extracellular volume) and vp (fractional plasma volume), using two vascular input functions. It is shown that IAUGC is a mixed parameter that can display correlation with Ktrans, ve and vp and ultimately has an intractable relationship with all three. Furthermore, it is demonstrated that the range over which IAUGC is taken and the nature of the vascular input function do not significantly affect this relationship.

[1]  M. Knopp,et al.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations , 2005, British Journal of Cancer.

[2]  Geoffrey J. M. Parker,et al.  Tracer Kinetic Modelling for T1-Weighted DCE-MRI , 2005 .

[3]  Alan Jackson,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology , 2005 .

[4]  Alan Jackson,et al.  Comparative study of methods for determining vascular permeability and blood volume in human gliomas , 2004, Journal of magnetic resonance imaging : JMRI.

[5]  A. Huvos,et al.  VEGF Expression in Osteosarcoma Correlates with Vascular Permeability by Dynamic MRI , 2004, Clinical orthopaedics and related research.

[6]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[7]  W. Press,et al.  Numerical Recipes in C++: The Art of Scientific Computing (2nd edn)1 Numerical Recipes Example Book (C++) (2nd edn)2 Numerical Recipes Multi-Language Code CD ROM with LINUX or UNIX Single-Screen License Revised Version3 , 2003 .

[8]  Evaluation of area under curve (Gd) data derived from DCE-MRI time series in brain tumours , 2003 .

[9]  J R Griffiths,et al.  Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. , 2003, The British journal of radiology.

[10]  Hon J. Yu,et al.  Measurement of Volumetric and Vascular Changes with Dynamic Contrast Enhanced MRI for Cancer Therapy Monitoring , 2002, Technology in cancer research & treatment.

[11]  Jamal Zweit,et al.  Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. , 2002, Journal of the National Cancer Institute.

[12]  A. Padhani,et al.  Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.

[13]  D P Dearnaley,et al.  Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.

[14]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[15]  J. Oakley,et al.  Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate. , 1999, The British journal of radiology.

[16]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[17]  M V Knopp,et al.  Evaluation of angiogenesis and perfusion of bone marrow lesions: Role of semiquantitative and quantitative dynamic MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[18]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[19]  O. Nalcioglu,et al.  Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic GD‐DTPA‐Albumin enhanced and diffusion‐weighted MRI , 1998, Magnetic resonance in medicine.

[20]  K. Kwong,et al.  Non-invasive in vivo mapping of tumour vascular and interstitial volume fractions. , 1998, European journal of cancer.

[21]  R. Murakami,et al.  Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[22]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[23]  E. Rostrup,et al.  Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.

[24]  William H. Press,et al.  Numerical Recipes in C, 2nd Edition , 1992 .

[25]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[26]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.